Menu

PubMed-Indexed Abstracts to Include COI Statements

Expressions of concern will also be linked in study summaries. 

Apr 19, 2017
Tracy Vence

© BRYAN SATALINOLast year, in a letter to National Institutes of Health (NIH) Director Francis Collins and National Library of Medicine (NLM) Acting and Deputy Director Betsy Humphreys, more than 60 scientists and physicians requested that authors’ conflicts of interests accompany study abstracts indexed on PubMed. Last month, the NIH and NLM began doing just that.

In a March Technical Bulletin post, the NLM noted that “PubMed will include conflict of interest statements below the abstract when these statements are supplied by the publisher.” Publisher-provided disclosures will appear when a user clicks to expand a menu beneath the digital object identifier (doi) information on an abstract.

“Adding disclosures about researchers’ financial relationships with drug, food, chemical, and other industries makes PubMed search results even more useful than they already are,” Michael Jacobson, president of the Center for Science in the Public Interest, which cosigned the 2016 letter to Collins and Humphreys, said in a statement. “We thank the National Library of Medicine for adding this feature and hope journalists who rely on PubMed make consistent use of it when reporting on studies related to nutrition and health.”

The NLM said it will also link expressions of concern in PubMed abstracts and move such notices up from the comments section to just below the author information.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.